Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial

INTRODUCTION: Early eradication of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis is desirable. Prospective studies are challenging owing to the feasibility of recruiting patients with a rare event in an orphan disease. Our prior randomised study (Staph Aureus Resistance-Treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, Fiona, Caldwell, Ellen, Mayer-Hamblett, Nicole, Goss, Christopher H., Muhlebach, Marianne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Study Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720546/
https://www.ncbi.nlm.nih.gov/pubmed/36478917
http://dx.doi.org/10.1183/23120541.00190-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720546/
https://www.ncbi.nlm.nih.gov/pubmed/36478917
http://dx.doi.org/10.1183/23120541.00190-2022

Ejemplares similares